Q4 2026 Advanced Enzyme Technologies Ltd Earnings Call Transcript

May 11, 2026 / 03:30 AM GMT

Release Date Price: ₹369.8 (-5.28%)

Transcript

Key Points

Positve

Advanced Enzyme Technologies Ltd (BOM:540025) reported its highest ever quarterly and annual revenue for the fiscal year ended March 2026, with a 22% year-on-year growth in Q4 and a 17% increase for the full year.
The company's EBITDA for the quarter grew by 39% year-on-year, maintaining a strong margin of 31%.
Profit after tax for the quarter showed a significant growth of 69% year-on-year, indicating strong profitability.
The human healthcare segment, the largest division, reported a 24% year-on-year growth in Q4, contributing 63% of total revenue.
The company is expanding its R&D capabilities, with a new center in Nasik expected to become operational later this fiscal year, enhancing product development and innovation.

Negative

The company faces potential near-term margin pressures due to increasing geopolitical disruptions affecting input costs such as fuel, salt, and logistics.
Despite growth, the profit after tax margin decreased from 28% in FY25 to 23% in FY26, indicating some pressure on profitability.
The U.S. market remains challenging with significant inflationary pressures and uncertainties affecting consumer spending.
Gross margins have moderated on a sequential basis, raising concerns about cost management and pricing strategies.
The company is experiencing inventory build-up due to supply chain uncertainties, which could impact working capital efficiency.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ADEN.NS - Advanced Enzyme Technologies Ltd
Q4 2026 Advanced Enzyme Technologies Ltd Earnings Call
May 12, 2026 / 03:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen. I'm Aakash, moderator for the conference call.

Welcome to Advanced Enzyme Technologies Limited, Q4 and FY26 Earnings Conference Call.

As a reminder, all participants will be in listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touch tone telephone. Please note, this conference is being recorded.

I would now like to hand over the floor to Mr. Rohlak Sharaf.

Thank you and over to you, sir.

-----------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.